Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-08

FDA Approved: PROTOPAM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a Baxter Healthcare supplemental application for Protopam Chloride (pralidoxime chloride), potentially updating labeling and indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROTOPAM CHLORIDE (Pralidoxime chloride)

Snippet

SUPPL AP for PROTOPAM CHLORIDE (PRALIDOXIME CHLORIDE)